Sharps Technology, Inc. (STSS)
NASDAQ: STSS · Real-Time Price · USD
0.0338
-0.0085 (-20.09%)
Mar 31, 2025, 1:19 PM EDT - Market open
Company Description
Sharps Technology, Inc., a medical device company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States.
The company provides safety syringe products comprising Securgard, Sologard, and Sharps Provensa that are ultra-low waste syringes for passive, and safety and reuse prevention features, as well as develops prefillable syringe systems.
Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.
Sharps Technology, Inc.
| Country | United States |
| Founded | 2017 |
| IPO Date | Apr 14, 2022 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 57 |
| CEO | Robert Hayes |
Contact Details
Address: 105 Maxess Road, Suite 124 Melville, New York 11747 United States | |
| Phone | 631 574 4436 |
| Website | sharpstechnology.com |
Stock Details
| Ticker Symbol | STSS |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.25 |
| CIK Code | 0001737995 |
| CUSIP Number | 82003F101 |
| ISIN Number | US82003F1012 |
| Employer ID | 82-3751728 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Robert M. Hayes | Chief Executive Officer and Director |
| Andrew R. Crescenzo CPA | Chief Financial Officer |
| Ben Scheu | Senior Director of Sales |
| Frank Parrado | Corporate Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 28, 2025 | 8-K | Current Report |
| Mar 27, 2025 | 10-K | Annual Report |
| Mar 20, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 20, 2025 | 8-K | Current Report |
| Mar 14, 2025 | 8-K | Current Report |
| Feb 11, 2025 | DEF 14A | Other definitive proxy statements |
| Feb 7, 2025 | EFFECT | Notice of Effectiveness |
| Feb 5, 2025 | SCHEDULE 13G | Filing |
| Jan 31, 2025 | SCHEDULE 13G | Filing |
| Jan 31, 2025 | AW | Amendment Withdrawal Request |